Back

Boston Scientific recalls Infinion CX Lead in most serious FDA device category

Verifying
  • Boston Scientific recalled its Infinion CX Lead under the FDA’s most serious device-recall classification.
  • 1,081 serious injuries were documented as of May 27, 2026, with no reported deaths.
  • The recall covers unused inventory; implanted patients require standard clinical follow-up only.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.